Research, partnerships and case studies

How New Zealand’s ESR and Awanui Labs achieve ultrafast outbreak detection with Solu and Nanopore sequencing

New Zealand’s Institute of Environmental Science and Research (ESR) and Awanui Labs present an ultrafast outbreak surveillance model using nanopore sequencing and Solu's bioinformatics
Read more
Read more

New publication: Solu: a cloud platform for real-time genomic pathogen surveillance

Our new study validating the Solu platform for fast, user-friendly and privacy-focused outbreak response has been published in BMC Bioinformatics.
Read more
Read more

Rapid Genomic Surveillance of Streptococcus pyogenes Using a No-Code Platform

Rapid genomic analysis of Streptococcus pyogenes isolates reveals insights into antibiotic resistance and transmission dynamics
Read more
Read more

Plasmid Analysis Reveals Potential Horizontal Gene Transfer Events in Hospital-Associated Infections

This is a poster presented at the NSCMID 2024 conference.
Read more
Read more

Solu Platform detects interhospital transmission of carbapenemase-producing plasmids: case study with Enterobacter hormaechei isolates

We analyse a set of Enterobacter hormaechei isolates with Solu Platform and show how antimicrobial resistance can spread through horizontally transferred plasmids.
Read more
Read more

Researchers find new antimicrobial resistance patterns in food-borne E.coli and Salmonella

Solu featured in 2 new publications examining food-borne pathogens in the UAE
Read more
Read more

Validation of Solu Platform's Phylogeny Pipeline Using a Salmonella Bareilly Outbreak Dataset

Validating Solu's phylogeny pipeline with a 2012 Salmonella Bareilly outbreak dataset.
Read more
Read more

Exploring Candida auris nosocomial outbreaks with Solu Platform

We used Solu Platform to analyze a dataset of 21 Candida auris samples and gained insights into an outbreak.
Read more
Read more

Solu to Enable a Cedars-Sinai Medical Center Research Study on Epidemiological and Antibiotic Resistance of Hospital Infections with Genomics

Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.
Read more
Read more

Explore the Most Comprehensive Set of Acinetobacter baumannii Genomes on Solu

You can now view the most comprehensive dataset of 100 diverse Acinetobacter baumannii genomes directly on Solu!
Read more
Read more